Intra- and postoperative catumaxomab in patients with epithelial ovarian cancer: safety and two-year efficacy results from a multicentre, single-arm, phase II study

od Sehouli, J, Reinthaller, A, Marth, C, Reimer, D, Reimer, T, Stummvoll, W, Angleitner-Boubenizek, L, Brandt, B, Chekerov, R
Izdano 2014

Interferon-gamma in the first-line therapy of ovarian cancer: a randomized phase III trial

od Windbichler, G H, Hausmaninger, H, Stummvoll, W, Graf, A H, Kainz, C, Lahodny, J, Denison, U, Müller-Holzner, E, Marth, C
Izdano 2000

Interdisciplinary S2k Guidelines for the Diagnosis and Treatment of Endometriosis: Short Version – AWMF Registry No. 015–045, August 2013

od Ulrich, U., Buchweitz, O., Greb, R., Keckstein, J., von Leffern, I., Oppelt, P., Renner, S. P., Sillem, M., Stummvoll, W., Schweppe, K.-W.
Izdano 2013

National German Guideline (S2k): Guideline for the Diagnosis and Treatment of Endometriosis : Long Version – AWMF Registry No. 015-045

od Ulrich, U., Buchweitz, O., Greb, R., Keckstein, J., von Leffern, I., Oppelt, P., Renner, S. P., Sillem, M., Stummvoll, W., De Wilde, R.-L., Schweppe, K.-W.
izdano v Geburtshilfe Frauenheilkd (2014)

Indications and Route of Hysterectomy for Benign Diseases. Guideline of the DGGG, OEGGG and SGGG (S3 Level, AWMF Registry No. 015/070, April 2015)

od Neis, K. J., Zubke, W., Römer, T., Schwerdtfeger, K., Schollmeyer, T., Rimbach, S., Holthaus, B., Solomayer, E., Bojahr, B., Neis, F., Reisenauer, C., Gabriel, B., Dieterich, H., Runnenbaum, I. B., Kleine, W., Strauss, A., Menton, M., Mylonas, I., David, M., Horn, L-C., Schmidt, D., Gaß, P., Teichmann, A. T., Brandner, P., Stummvoll, W., Kuhn, A., Müller, M., Fehr, M., Tamussino, K.
izdano v Geburtshilfe Frauenheilkd (2016)